|
J Biol Chem, Vol. 275, Issue 17, 12453-12462, April 28, 2000
Identification of a Nuclear Respiratory Factor-1 Binding Site
within the Core Promoter of the human polio virus
receptor/CD155 Gene*
David
Solecki §,
Günter
Bernhardt¶ ,
Martin
Lipp¶, and
Eckard
Wimmer
From the Department of Molecular Genetics and
Microbiology, School of Medicine, State University of New York at Stony
Brook, Stony Brook, New York 11794 and
¶ Max-Delbrück-Centrum für Molekulare Medizin,
Robert-Rössle-Stra e 10, 13092 Berlin, Germany
In this report we describe a
cis-acting element within the core promoter of the
CD155 gene specifying the polio virus receptor that is
bound by the nuclear respiratory factor-1 (NRF-1) transcription factor.
DNase I footprint analysis identified a nuclear protein binding site
from 282 to 264 nucleotides upstream of the translation initiation
codon of the CD155 gene, which we have called foot print IV
(FPIV). Linker scanning mutagenesis revealed that a tandem repeat
motif, GCGCAGGCGCAG, located within FPIV was essential for the basal
activity of the CD155 core promoter. The results of the electrophoretic
mobility shift assay experiments suggested that identical FPIV binding
activities were present in a variety of nuclear extracts and that the
tandem repeat was essential for binding. A one-hybrid screen was then
carried out using FPIV as bait to clone the cDNA of the FPIV
binding factor. The sequences of the cDNAs that were cloned from
the screen were identical to NRF-1, a result that was confirmed by
further electrophoretic mobility shift assay experiments.
Overexpression of full-length NRF-1 and a dominant-negative form of
NRF-1 modulated reporter gene expression driven by the core promoter.
Remarkably, CD155 is the first gene shown to be regulated
by NRF-1 that possesses an expression profile during embryogenesis
correlating with this factor's proposed role in the development of the
vertebrate optic system. We propose that NRF-1, which has been shown by
others to be expressed during embryogenesis in animal systems, may be involved in regulating the expression of CD155 at specific stages of
central nervous system development.
*
This work was supported in part by National Institutes of
Health Grant AI39485.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Member of the graduate program in Molecular and Cellular Biology,
SUNY at Stony Brook and recipient a grant from the Deutscher Akademischer Austauschdienst. To whom correspondence should be addressed: Laboratory of Developmental Neurobiology, The Rockefeller University, New York, NY 10021. Tel.: 212-327-7211; Fax: 212-327-7140; E-mail:soleckd@rockvax.rockefeller.edu.
Supported by Grant BE1886/1-2 from the Deutsche Forschungsgemeinschaft.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. K. Merrill, G. Bernhardt, J. H. Sampson, C. J. Wikstrand, D. D. Bigner, and M. Gromeier
Poliovirus receptor CD155-targeted oncolysis of glioma
Neuro-oncol,
July 1, 2004;
6(3):
208 - 217.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Solecki, M. Gromeier, S. Mueller, G. Bernhardt, and E. Wimmer
Expression of the Human Poliovirus Receptor/CD155 Gene Is Activated by Sonic Hedgehog
J. Biol. Chem.,
July 5, 2002;
277(28):
25697 - 25702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Ansardi, D. C. Porter, C. A. Jackson, G. Y. Gillespie, and C. D. Morrow
RNA Replicons Derived from Poliovirus Are Directly Oncolytic for Human Tumor Cells of Diverse Origins
Cancer Res.,
December 1, 2001;
61(23):
8470 - 8479.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|